Nasal spray formulation of naloxone hydrochloride, to be sold as Narcan and indicated for emergency treatment of opioid overdose, won approval from the FDA. It’s the first non-injectable form of naloxone to be cleared for U.S. sale. Via MedPage Today. Posted November 19, 2015.
–Alanna McCatty
